RICHELSON ELLIOTT has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LAFON PHARMA, QUEST PHARMATECH INC and EKWURIBE NNOCHIRI N.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Peptides | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Richelson Elliott | 11 |
#2 | Pang Yuan-Ping | 5 |
#3 | Mccormick Daniel J | 5 |
#4 | Cusack Bernadette Marie | 3 |
#5 | Boules Mona | 3 |
#6 | Fauq Abdul H | 3 |
#7 | Tyler Beth Marie | 3 |
#8 | Carlier Paul R | 3 |
#9 | Fauq Abdul | 3 |
#10 | Phillips Kenneth S | 2 |
Publication | Filing date | Title |
---|---|---|
US2012220665A1 | Inhibiting Neurotransmitter Reuptake | |
US2009062212A1 | Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2 |